251 related articles for article (PubMed ID: 21142815)
1. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.
Alp E; Menevse S; Tulmac M; Yilmaz A; Yalcin R; Cengel A
Genet Test Mol Biomarkers; 2011 Apr; 15(4):193-202. PubMed ID: 21142815
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
Alp E; Yilmaz A; Tulmac M; Ugras Dikmen A; Cengel A; Yalcin R; Menevse ES
Kaohsiung J Med Sci; 2017 Feb; 33(2):78-85. PubMed ID: 28137415
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population.
Alp E; Menevse S; Tulmac M; Kan D; Yalcin R; Erkan AF; Cengel A
DNA Cell Biol; 2009 Jul; 28(7):343-50. PubMed ID: 19435423
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Slimani A; Addad F; Hassine M; Hamda KB; Najah M; Maatouk F; Rouis M; Slimane MN
Coron Artery Dis; 2011; 22(6):388-93. PubMed ID: 21606841
[TBL] [Abstract][Full Text] [Related]
5. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
[TBL] [Abstract][Full Text] [Related]
6. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
9. The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population.
Tangurek B; Ozer N; Sayar N; Terzi S; Yilmaz H; Dayi SU; Ciloglu F; Aksu H; Asilturk R; Cagil A
Heart Vessels; 2006 Sep; 21(5):285-90. PubMed ID: 17151815
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
11. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
12. Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients.
Mishra A; Srivastava A; Mittal T; Garg N; Mittal B
Clin Chim Acta; 2012 Oct; 413(19-20):1668-74. PubMed ID: 22664146
[TBL] [Abstract][Full Text] [Related]
13. Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.
Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
J Diabetes Complications; 2013; 27(3):255-61. PubMed ID: 23182401
[TBL] [Abstract][Full Text] [Related]
14. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
[TBL] [Abstract][Full Text] [Related]
15. Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population.
Park S; Park HY; Park C; Ko YG; Im EK; Jo I; Shin C; Lee JB; Shim WH; Cho SY; Jang Y
Yonsei Med J; 2004 Jun; 45(3):428-34. PubMed ID: 15227729
[TBL] [Abstract][Full Text] [Related]
16. The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.
Ayaz G; Batar B; Kanigur G; Guven M; Onaran I; Karadag B; Ilerigelen B; Dirican A; Ulutin T
Gene; 2013 Sep; 527(1):301-5. PubMed ID: 23816407
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
[TBL] [Abstract][Full Text] [Related]
18. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
[TBL] [Abstract][Full Text] [Related]
19. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
Opstad TB; Pettersen AA; Weiss TW; Akra S; Øvstebø R; Arnesen H; Seljeflot I
Clin Chim Acta; 2012 Jan; 413(1-2):113-20. PubMed ID: 21963461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
